Topical bioequivalence advisory committee
Executive Summary
FDA's Office of Generic Drugs will present an update on its research into topical bioequivalence to the Pharmaceutical Science Advisory Committee at April 14 meeting. Discussion will focus on developing a decision tree that would classify topical products based on their site of action and the degree of formulation similarity. [Editor's Note: To 1watch a webcast of this meeting, go to 2www.FDAAdvisoryCommittee.com]. During the April 13-14, meeting, the committee will also discuss highly variable drugs, inhalation products and process analytical technologies (3"The Pink Sheet" March 22, 2004, In Brief)...